{"id":"intranasal-challenge-drug","safety":{"commonSideEffects":[{"rate":null,"effect":"Nasal irritation"},{"rate":null,"effect":"Transient anxiety or distress"},{"rate":null,"effect":"Headache"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Intranasal challenge drugs are administered via nasal inhalation to induce acute neurobiological or behavioral responses in controlled research environments. These agents are typically used in Phase 3 psychiatric studies to model disease states, test treatment efficacy, or investigate underlying pathophysiology. The specific mechanism depends on the active agent, which is not identified in the available information.","oneSentence":"An intranasal challenge agent used to provoke or test physiological responses in psychiatric research settings.","_ai_confidence":"low"},"_scrapedAt":"2026-03-28T01:16:44.132Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Psychiatric research and challenge testing (Phase 3 investigational use)"}]},"trialDetails":[{"nctId":"NCT06753474","phase":"PHASE1","title":"A/Texas Flu Challenge","status":"RECRUITING","sponsor":"Emory University","startDate":"2025-02-04","conditions":"Influenza","enrollment":50},{"nctId":"NCT07419880","phase":"PHASE2","title":"Re-challenge Immunotherapy With Cromolyn, TQB2102, and Panpulimab in Immune-Refractory Triple Negative Breast Cancer","status":"NOT_YET_RECRUITING","sponsor":"Fudan University","startDate":"2026-01-30","conditions":"Triple -Negative Breast Cancer","enrollment":46},{"nctId":"NCT06620185","phase":"NA","title":"GEneRating Mucosal Immunity After INfluenzA Infection and Vaccination in Lung and Lymphoid TissuE","status":"RECRUITING","sponsor":"Imperial College London","startDate":"2025-04-16","conditions":"Influenza","enrollment":36},{"nctId":"NCT05571878","phase":"NA","title":"Is Brain Insulin Resistance a Feature of the Biology of Depression in Adolescents","status":"ACTIVE_NOT_RECRUITING","sponsor":"Centre for Addiction and Mental Health","startDate":"2021-09-01","conditions":"Major Depressive Disorder, Depression","enrollment":24},{"nctId":"NCT06375772","phase":"PHASE2","title":"A Controlled Human Rhinovirus Infection Study of 2-Deoxy-D-Glucose in Healthy Adults","status":"TERMINATED","sponsor":"G.ST Antivirals GmbH","startDate":"2024-04-02","conditions":"Acute Nasopharyngitis","enrollment":64},{"nctId":"NCT02402465","phase":"PHASE4","title":"Factors Involved in Dymista's Superior Clinical Efficacy in the Treatment of Seasonal Allergic Rhinitis","status":"COMPLETED","sponsor":"University of Chicago","startDate":"2015-02","conditions":"Allergic Rhinitis","enrollment":22},{"nctId":"NCT06251635","phase":"NA","title":"Effects of Antipsychotics on Brain Insulin Action in Females","status":"RECRUITING","sponsor":"Centre for Addiction and Mental Health","startDate":"2024-06-03","conditions":"Insulin Resistance, Menstrual Cycle, Type 2 Diabetes","enrollment":15},{"nctId":"NCT04690335","phase":"PHASE2","title":"Human Challenge Study to Evaluate the Efficacy of MV-012-968 Vaccine","status":"COMPLETED","sponsor":"Meissa Vaccines, Inc.","startDate":"2020-12-29","conditions":"RSV Infection","enrollment":60},{"nctId":"NCT02933411","phase":"","title":"Low VW Activity in Adolescent HMB","status":"UNKNOWN","sponsor":"Baylor College of Medicine","startDate":"2017-01-05","conditions":"Von Willebrand Factor Deficiency","enrollment":120},{"nctId":"NCT01568528","phase":"PHASE2","title":"Oxytocin as Adjunctive Treatment of Schizophrenia","status":"COMPLETED","sponsor":"Emory University","startDate":"2013-03","conditions":"Schizophrenia","enrollment":39},{"nctId":"NCT03431961","phase":"NA","title":"Nasal Allergen Challenge - Reproducibility of Biomarkers and Effect of Topical Steroid Treatment","status":"UNKNOWN","sponsor":"Gail Gauvreau","startDate":"2018-03-07","conditions":"Allergic Asthma","enrollment":20},{"nctId":"NCT02116998","phase":"PHASE2","title":"Safety, Tolerability, and Efficacy Study of Prophylactic S. Pneumoniae Vaccine Following Challenge With S. Pneumoniae","status":"COMPLETED","sponsor":"Genocea Biosciences, Inc.","startDate":"2014-09","conditions":"Pneumococcal Infections, Pneumonia, Pneumococcal","enrollment":98},{"nctId":"NCT00400998","phase":"PHASE2","title":"Investigate Two Trial Models; Vienna Challenge Chamber (in and Out of Season) and Park Study (in Season) Using a Drug for Seasonal Allergic Rhinitis","status":"COMPLETED","sponsor":"Research Consult GmbH","startDate":"2006-03","conditions":"Allergic Rhinitis, Rhinitis, Allergic, Seasonal","enrollment":41},{"nctId":"NCT03296917","phase":"PHASE2","title":"Study Examining PrEP-001 in Subjects With Asthma","status":"COMPLETED","sponsor":"Hvivo","startDate":"2015-12-11","conditions":"Asthma","enrollment":60},{"nctId":"NCT01760473","phase":"PHASE3","title":"Reinforcing Effects of Intranasal (IN) Buprenorphine Versus Buprenorphine/Naloxone","status":"COMPLETED","sponsor":"New York State Psychiatric Institute","startDate":"2009-05","conditions":"Heroin Dependence","enrollment":27},{"nctId":"NCT00517946","phase":"","title":"A Study To Investigate If MRI Scanning Is Effective At Seeing What Hayfever Drugs Do In Nasal Passage.","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2007-03","conditions":"Seasonal Allergic Rhinitis, Sinusitis","enrollment":21}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_3","status":"active","brandName":"Intranasal challenge drug","genericName":"Intranasal challenge drug","companyName":"New York State Psychiatric Institute","companyId":"new-york-state-psychiatric-institute","modality":"Small molecule","firstApprovalDate":"","aiSummary":"An intranasal challenge agent used to provoke or test physiological responses in psychiatric research settings. Used for Psychiatric research and challenge testing (Phase 3 investigational use).","enrichmentLevel":3,"visitCount":1,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}